Your browser doesn't support javascript.
loading
PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progression.
Gagliano, Teresa; Shah, Kalpit; Gargani, Sofia; Lao, Liyan; Alsaleem, Mansour; Chen, Jianing; Ntafis, Vasileios; Huang, Penghan; Ditsiou, Angeliki; Vella, Viviana; Yadav, Kritika; Bienkowska, Kamila; Bresciani, Giulia; Kang, Kai; Li, Leping; Carter, Philip; Benstead-Hume, Graeme; O'Hanlon, Timothy; Dean, Michael; Pearl, Frances Mg; Lee, Soo-Chin; Rakha, Emad A; Green, Andrew R; Kontoyiannis, Dimitris L; Song, Erwei; Stebbing, Justin; Giamas, Georgios.
Afiliación
  • Gagliano T; Department of Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Falmer, Brighton, United Kingdom.
  • Shah K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland, USA.
  • Gargani S; Division of Immunology, Biomedical Sciences Research Center Alexander Fleming, Vari, Greece.
  • Lao L; Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Alsaleem M; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Nottingham, United Kingdom.
  • Chen J; Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Ntafis V; Division of Immunology, Biomedical Sciences Research Center Alexander Fleming, Vari, Greece.
  • Huang P; Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Ditsiou A; Department of Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Falmer, Brighton, United Kingdom.
  • Vella V; Department of Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Falmer, Brighton, United Kingdom.
  • Yadav K; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Bienkowska K; Department of Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Falmer, Brighton, United Kingdom.
  • Bresciani G; Department of Biochemistry and Biomedicine, School of Life Sciences, University of Sussex, Falmer, Brighton, United Kingdom.
  • Kang K; Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
  • Li L; Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, NIH, Durham, North Carolina, USA.
  • Carter P; Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, NIH, Durham, North Carolina, USA.
  • Benstead-Hume G; Division of Cancer, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London, United Kingdom.
  • O'Hanlon T; Bioinformatics Group, School of Life Sciences, University of Sussex, Falmer, Brighton, United Kingdom.
  • Dean M; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Bethesda, Maryland, USA.
  • Pearl FM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland, USA.
  • Lee SC; Bioinformatics Group, School of Life Sciences, University of Sussex, Falmer, Brighton, United Kingdom.
  • Rakha EA; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Green AR; Department of Haematology-Oncology, National University Cancer Institute, Singapore.
  • Kontoyiannis DL; National University Health System, Singapore.
  • Song E; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Nottingham, United Kingdom.
  • Stebbing J; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Nottingham, United Kingdom.
  • Giamas G; Division of Immunology, Biomedical Sciences Research Center Alexander Fleming, Vari, Greece.
J Clin Invest ; 130(6): 3188-3204, 2020 06 01.
Article en En | MEDLINE | ID: mdl-32125284
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Regulación Enzimológica de la Expresión Génica / Regulación Neoplásica de la Expresión Génica / Fosfatidilinositol 3-Quinasa Clase I / Fibroblastos / Neoplasias de la Mama Triple Negativas / Proteínas de Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: J Clin Invest Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Regulación Enzimológica de la Expresión Génica / Regulación Neoplásica de la Expresión Génica / Fosfatidilinositol 3-Quinasa Clase I / Fibroblastos / Neoplasias de la Mama Triple Negativas / Proteínas de Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: J Clin Invest Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos